Tseng Claire C, Bruner Steven D, Kohli Rahul M, Marahiel Mohamed A, Walsh Christopher T, Sieber Stephan A
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA.
Biochemistry. 2002 Nov 12;41(45):13350-9. doi: 10.1021/bi026592a.
The C-terminal thioesterase domain of the nonribosomal peptide synthetase producing the lipopetide surfactin (Srf TE) retains autonomous ability to generate the cyclic peptidolactone skeleton of surfactin when provided with a soluble beta-hydroxy-butyryl-heptapeptidyl thioester substrate. Utilizing the recently solved crystal structure [Bruner, S. D., et al. (2002) Structure 10, 301-310], the active-site nucleophile, Ser80, was changed to Cys, and the other members of the catalytic triad, Asp107 and His207, were changed to Ala, with the resulting mutants lacking detectable activity. Two cationic side chains in the active site, Lys111 and Arg120, were changed to Ala, causing an increased partitioning of the product to hydrolysis, as did a P26G mutant, mimicking the behavior of lipases. To evaluate recognition elements in substrates used by Srf TE, alterations to the fatty acyl group, the heptapeptide, and the thioester leaving group were made, and the resulting substrates were characterized for kinetic competency and flux of product to cyclization or hydrolysis. Alterations that could be accepted for cyclization were identified in all three parts of the substrate, although tolerance limits for changes varied. In addition, cocrystal structures of Srf TE with dipeptidyl boronate inhibitors were solved, illustrating the critical binding determinants of the substrate. On the basis of the structures and biochemical data, the cyclizing conformation of the surfactin peptide was modeled into the enzyme active site.
产生脂肽表面活性素的非核糖体肽合成酶的C末端硫酯酶结构域(Srf TE),当提供可溶性β-羟基丁酰-七肽基硫酯底物时,保留自主生成表面活性素环肽内酯骨架的能力。利用最近解析的晶体结构[布鲁纳,S. D.等人(2002年)《结构》10,301 - 310],将活性位点亲核试剂Ser80突变为Cys,并将催化三联体的其他成员Asp107和His207突变为Ala,所得突变体缺乏可检测到的活性。活性位点中的两个阳离子侧链Lys111和Arg120被突变为Ala,导致产物向水解的分配增加,P26G突变体也是如此,模拟了脂肪酶的行为。为了评估Srf TE所使用底物中的识别元件,对脂肪酰基、七肽和硫酯离去基团进行了改变,并对所得底物的动力学能力以及产物向环化或水解的通量进行了表征。尽管变化的耐受限度不同,但在底物的所有三个部分都确定了可被环化接受的改变。此外,解析了Srf TE与二肽基硼酸酯抑制剂的共晶体结构,阐明了底物的关键结合决定因素。基于这些结构和生化数据,将表面活性素肽的环化构象模拟到酶活性位点中。